ArticleJournal of oncology2022

Identification and Validation of a Novel Multiomics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma.

Zhicheng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.